Symptom Prevalence among People Affected by Advanced and Progressive Neurological Conditions—a Systematic Review

Solano JP , Gomes B , Higginson IJ . A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease, and renal disease. J Pain Symptom Manage 2006; 31 (1):58–69.

Doyle D , Hanks G , Cherny NI , Calman K (eds). Oxford Textbook of Palliative Medicine. 3^rd edition. Oxford: Oxford University Press, 2004.

McKenna C , MacLeod R. Access to palliative care for people with motor neurone disease in New Zealand [see comment]. N Z Med J 2005; 16: 118(1222).

United Kingdom Department of Health. The National Service Framework for Long-Term Conditions. London: HMSO, 2005.

Voltz R , Bernat JL , Borasio GD , Maddocks I , Oliver D , Portenoy RK (eds). Palliative Care in Neurology. Oxford: Oxford University Press, 2004.

Addington-Hall J , Higginson I (eds). Palliative Care for Non-Cancer Patients. Oxford: Oxford University Press, 2001.

Davies E , Higginson I (eds). Better Palliative Care for Older People. Europe: World Health Organization, 2004.

Fallon M , Hanks G (eds). ABC of Palliative Care. 2^nd edition. Europe: BMJ Blackwell Publishing, 2006.

Playford D , Thompson AJ (eds). Neurological Rehabilitation of Parkinson's Disease. London: Taylor and Francis, 2007.

Percival R , Hobson P (eds). Parkinson's Disease: studies in psychological and social care. UK: British Psychological Society Blackwell, 1999.

Teunissen S , Wesker W , Kruitwagen C , de Haes H , Voest EE dGA. Symptom prevalence in patients with incurable cancer: a systematic review. J Pain Symptom Manag 2007; 34 (1):94–104.

Lee M , Walker RW , Hildreth TJ , Prentice WM . A survey of pain in idiopathic Parkinson's disease. J Pain Symptom Manag 2006; 32 (5):462–469.

Murtagh F.E.M , Addington-Hall J , Higginson IJ . The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis 2007; 14 (1):82–99.

Hearn J , Higginson IJ . Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. Qual Health Care 1999; 8 (4):219–227.

Thompson S. Just Invisible. Report on living with the advanced stage of Parkinson's. UK: Parkinson's Disease Society, 2005.

National Cancer Research Institute. Report of the NCRI Strategic Planning Group on Supportive and Palliative Care. London: NCRI, 2004.

Chang VT , Hwang SS , Feuerman M , Kasimis BS , Thaler HT . The memorial symptom assessment scale short form (MSAS-SF). Cancer 2000; 89 (5):1162–1171.

Higginson IJ , Hart S , Silber E , Burman R , Edmonds P. Symptom prevalence and severity in people severely affected by multiple sclerosis. J Palliat Care 2006; 22 (3):158–165.

Ganzini L , Johnston WS , Silveira MJ . The final month of life in patients with ALS. Neurology 2002; 59 (3):428–431.

O'Brien T , Welsh J , Dunn FG . ABC of palliative care: nonmalignant conditions. BMJ 1998; 316: 286–289.

O'Brien T , Kelly M , Saunders C. Motor neurone disease: a hospice perspective. BMJ 1992; 304 (6825):471–473.

Addington-Hall J , Fakhoury W , McCarthy M. Specialist palliative care in nonmalignant disease. Palliat Med 1998; 12 (6):417–427.

Kite S , Jones K , Tookman A. Specialist palliative care and patients with noncancer diagnoses: the experience of a service. Palliat Med 1999; 13 (6):477–484.

Norris F. Motor neurone disease: a hospice perspective. BMJ 1992; 304: 459–460.

Higginson IJ , Vivat B , Silber E , Saleem T , Burman R , Hart S , . Study protocol: delayed intervention randomised controlled trial within the Medical Research Council (MRC) Framework to assess the effectiveness of a new palliative care service. BMC Palliat Care 2006; 5: 7.

Hicks F , Corcoran G. Should hospices offer respite admissions to patients with motor neurone disease? Palliat Med 1993; 7 (2):145–150.

Charles T , Swash M. Amyotrophic lateral sclerosis: current understanding. [Review.70 refs.] J Neurosci Nurs 2001; 33 (5):245–253.

Borasio GD , Rogers A , Voltz R. Palliative medicine in nonmalignant neurological disorders. In: Doyle D , Hanks G , Cherny N , Caiman K (eds). Oxford Textbook of Palliative Medicine. 3^rd edition. Oxford: Oxford University Press; 2004, pp. 925–934.

Barby FMT , . Palliative care in motor neurone disease. Int J Palliat Nurs 1995; 1 (4):183–184.

Swingler RJ , Compston DA . The morbidity of multiple sclerosis. Q J Med 1992; 83 (300):325–337.

Ben-Zacharia AB , Lublin FD . Palliative care in patients with multiple sclerosis. Neurol Clin 2001; 19 (4):801–827.

Auspurger RR . Bladder dysfunction in multiple sclerosis. In: Maloney FP , Burke JS , Ringel SP (eds). Interdisciplinary Rehabilitation of Multiple Sclerosis and Neuromuscular Disorders. Philadelphia: JB Lippincott; 1985, pp. 48–61.

Jones R , D'eath C , Harnsford J , Hutchinson H , Hyde L , Thurlow L , Spanton L. The needs of people with Parkinson's disease and their families: the Parkinson's disease study, Devon and Cornwall, 1989–92. In: Percival R , Hobson P (eds). Parkinson's Disease: studies in psychological and social care; 1999, p. 60–78.

Sjostrom A , Holmberg B , Strang P. Parkinson-plus patients—an unknown group with severe symptoms. J Neurosci Nurs 2002; 34 (6):314–319.

Newrick PG , Langton-Hewer R. Motor neurone disease: Can we do better? A study of 42 patients. BMJ Clin Res Ed 1984; 289 (6444):539–542.

Brooks DJ . Diagnosis and management of atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry 2002; 72(suppl 1): 110–116.

Kiebert GM , Green C , Murphy C , Mitchell JD , O'Brien M , Burrell A , . Patients’ health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis. J Neurol Sci 2001; 191(1-2): 87–93.

Findley L , Aujla M , Bain PG , Baker M , Beech C , Bowman C , . Direct economic impact of Parkinson's disease: a research survey in the United Kingdom. Mov Disord 2003; 18 (10):1139–1145.

Hely MA , Morris JG , Reid WG , Trafficante R. Sydney multicenter study of Parkinson's disease: non-L-dopa-responsive problems dominate at 15 years. Mov Disord 2005; 20 (2):190–199.

Oxtoby M. Parkinson's Disease Patients and Their Social Needs. Parkinson's Disease Society, 1982.

Schrag A , Ben-Shlomo Y , Quinn N. How common are complications of Parkinson's disease? J Neurol 2002; 249 (4):419–423.

Clough C , Blockley A. Parkinson's disease and related disorders. In: Voltz R , Bernat JL , Borasio GD , Maddocks I , Oliver D , Portenoy RK (eds). Palliative Care in Neurology. Oxford: Oxford University Press; 2006, pp. 48–58.

Miller RG , Rosenberg JA , Gelinas DF , Mitsumoto H , Newman D , Sufit R , . Practice parameter: the care of the patient with amyotrophic lateral sclerosis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology: ALS Practice Parameters Task Force. Neurology 1999; 52 (7):1311–1323.

Oliver D. The quality of care and symptom control—the effects on the terminal phase of ALS/MND. J Neurol Sci 1996; 139(suppl): 134–136.

Mandler RN , Anderson FA Jr. , Miller RG , Clawson L , Cudkowicz M , Del BM , . The ALS Patient Care Database: insights into end-of-life care in ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2001; 2 (4):203–208.

Neudert C , Oliver D , Wasner M , Borasio GD . The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol 2001; 248 (7):612–616.

Ehde DM , Gibbons LE , Chwastiak L , Bombardier CH , Sullivan MD , Kraft GH . Chronic pain in a large community sample of persons with multiple sclerosis. Mult Scler 2003; 9 (6):605–611.

Goetz CG , Tanner CM , Levy M , Wilson RS , Garron DC . Pain in Parkinson's disease. Mov Disord 1986; 1 (1):45–49.

Tison F , Wenning GK , Volonte MA , Poewe WR , Henry P , Quinn NP . Pain in multiple system atrophy. J Neurol 1996; 243 (2):153–156.

Nilsson H , Ekberg O , Olsson R , Hindfelt B. Quantitative aspects of swallowing in an elderly nondysphagic population [see comment]. Dysphagia 1996; 11 (3):180–184.

Abbott RA , Cox M , Markus H , Tomkins A. Diet, body size and micronutrient status in Parkinson's disease. Eur J Clin Nutr 1992; 46 (12):879–884.

Pfeiffer RF . Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2003; 2 (2):107–116.

Bronner G , Royter V , Korczyn AD , Giladi N. Sexual dysfunction in Parkinson's disease. J Sex Marital Ther 2004; 30 (2):95–105.

Boyce HW , Bakheet MR . Sialorrhea: a review of a vexing, often unrecognized sign of oropharyngeal and esophageal disease. J Clin Gastroenterol 2005; 39 (2):89–97.

Karlsen KH , Larsen JP , Tandberg E , Maeland JG . Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 66 (4):431–435.

Aarsland D , Litvan I , Larsen JP . Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001; 13 (1):42–49.

Hunter MD , Robinson IC , Neilson S. The functional and psychological status of patients with amyotrophic lateral sclerosis: some implications for rehabilitation. Disabil Rehabil 1993; 15 (3):119–126.

Hogg KE , Goldstein LH , Leigh PN . The psychological impact of motor neurone disease. Psychol Med 1994; 24 (3):625–632.

Grossman A , Bradley W. Psychosocial factors and cognition in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4(4):217–224.

Ondo WG , Tintner R , Voung KD , Lai D , Ringholz G. Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease. Mov Disord 2005; 20 (8):958–963.

Fénelon G , Mahieux F , Huon R , Ziégler M. Hallucinations in Parkinson's disease: prevalence, phenomenology and risk factors. Brain 2000; 123(Pt 4): 733–745.